Breaking News
eThalED Webinar Series: Current Standard Care & New Advances in Iron Chelation
TIF Webinar Fridays Are Back With A New Session on “Heart Disease In Thalassaemia”
Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in β-Thalassaemia
Thal e-Course Webinar Series: Iron Monitoring in Thalassaemia
Johnson & Johnson Pauses Clinical Trials For Its Covid-19 Vaccine Over Participant’s Illness
Hidden Victims Of The Pandemic: Blood Bank Stocks Run Low As India’s Healthcare System Buckles
New Video Series on Living With Thalassaemia by CDC & CAF
Fulcrum Therapeutics to Initiate Phase 1 Trial with FTX-6058 for Sickle Cell Disease
TIF Develops Mobile Application To Support Patients With Thalassaemia
Coming Up This Week: ”Iron Monitoring in Thalassaemia” Webinar for Patients
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country work
Projects
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Home
/
Sitemap
Sitemap
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Find out more
Okay, thanks
